Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Neoadjuvant immunotherapy for lung cancer comes with risks and benefits. This post is intended to highlight the benefits of a healthy gut microbiome for the lung cancer patient.
The top study, linked and excerpted below, explains that neoadjuvant immunotherapy for lung cancer patients can increase the overall survival of NSCLC patients. Unfortunately, immunotherapy carries a risk of side effects.
The solution? The NSCLC must follow the diet below to enhance their gut microbiome.
High fiber (25–35 g/day) → fuels beneficial bacteria (Faecalibacterium, Akkermansia)
Fermented foods → increase microbial richness
Omega-3 fats → reduce inflammation, support gut barrier
Polyphenols (berries, tea, olive oil) → promote anti-inflammatory microbes
Low refined sugar & emulsifiers → protect microbiome integrity
Breakfast:
Steel-cut oats with blueberries, ground flaxseed, and walnuts
Green tea
Lunch:
Lentil and vegetable soup (carrots, celery, onions, garlic)
Side of sauerkraut
Dinner:
Baked salmon with olive oil and herbs
Roasted Brussels sprouts
Quinoa
Snack:
Plain Greek yogurt with cinnamon
Breakfast:
Kefir smoothie with spinach, banana, chia seeds, and ginger
Lunch:
Chickpea salad with cucumber, tomato, parsley, olive oil, and lemon
Whole-grain pita
Dinner:
Stir-fried tofu with broccoli, shiitake mushrooms, and garlic
Brown rice
Snack:
Apple with almond butter
Breakfast:
Scrambled eggs with onions, spinach, and mushrooms
Whole-grain toast
Lunch:
Miso soup with seaweed and tofu
Side salad with mixed greens and olive oil
Dinner:
Grilled sardines or mackerel
Sweet potato
Steamed asparagus
Snack:
Handful of mixed nuts
Breakfast:
Overnight oats with kefir, raspberries, pumpkin seeds
Lunch:
Black bean and avocado bowl with red cabbage and cilantro
Dinner:
Roast chicken thigh
Lentils with onions and garlic
Roasted carrots
Snack:
Dark chocolate (≥70% cocoa, small portion)
Breakfast:
Yogurt with strawberries, flaxseed, and oats
Lunch:
Vegetable minestrone (beans, onions, tomatoes, zucchini)
Dinner:
Baked cod with olive oil
Barley
Sautéed kale
Snack:
Pear
Breakfast:
Smoothie with kefir, blueberries, spinach, and turmeric
Lunch:
Hummus with raw vegetables (carrots, bell peppers)
Whole-grain crackers
Dinner:
Tempeh or tofu with fermented kimchi
Brown rice
Bok choy
Snack:
Cottage cheese or plant-based yogurt
Breakfast:
Oatmeal with apples, cinnamon, and walnuts
Lunch:
Quinoa salad with chickpeas, olives, red onion, olive oil
Dinner:
Grilled trout or salmon
Roasted cauliflower
Lentils
Snack:
Green tea and berries
Fermented: kefir, yogurt, sauerkraut, kimchi, miso
Fiber-rich: oats, beans, lentils, barley, vegetables
Polyphenols: berries, olive oil, green tea, dark chocolate
Omega-3s: salmon, sardines, walnuts, flaxseed
Ultra-processed foods
Artificial sweeteners
Excess refined sugar
Emulsifiers (e.g., polysorbate-80)
Alcohol (or keep minimal)
Avoid probiotic supplements unless approved by the oncology team (some studies suggest they may reduce immunotherapy efficacy)
Food-based fermented foods are generally preferred
Adjust fiber gradually to avoid bloating
Modify texture if nausea or appetite loss occurs
I am a long-term survivor of an incurable blood cancer. I wish that I understood the importance of gut health when I was first diagnosed.
Scroll down the page, post a question or a comment if you’d like to learn more about evidence-based non-conventional lung cancer therapies.
Good luck,
Emerging evidence underscores gut microbiota’s role in modulating lung cancer immunotherapy outcomes, though specific impacts on immune checkpoint inhibitors (ICIs) and associated adverse events (AEs) require further clarity.
This review synthesizes findings from 15 studies examining gut microbiota-ICI interactions in non-small cell lung cancer (NSCLC), alongside studies investigating antibiotics, proton pump inhibitors (PPIs), probiotics, and diet as modulating factors.
Results indicate that Actinobacteria, Bacteroides, and Verrucomicrobiota correlate with positive ICI responses, while Bacillotashows variable associations; notably, Bacillota-enriched patients had fewer immunotherapy-related AEs.
The administration of antibiotics and PPIs within a month before ICIs was linked to diminished efficacy, whereas probiotics correlated with enhanced outcomes. Plant-based diets are also aligned with dietary patterns supportive of ICIs.
These findings suggest that analyzing gut microbiota composition could improve the ability to predict NSCLC patient responses to ICIs. Additionally, judicious use of antibiotics, PPIs, probiotics, and dietary adjustments may optimize immunotherapy outcomes and mitigate adverse effects…
Neoadjuvant immunotherapy for lung cancer Neoadjuvant immunotherapy for lung cancer Neoadjuvant immunotherapy for lung cancer